Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.00
-0.33 (-3.96%)
At close: Dec 5, 2025, 4:00 PM EST
8.42
+0.42 (5.25%)
After-hours: Dec 5, 2025, 4:46 PM EST
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $139.80 million as of December 5, 2025. Its market cap has increased by 145.22% in one year.
Market Cap
139.80M
Enterprise Value
134.25M
1-Year Change
145.22%
Ranking
Category
Stock Price
$8.00
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $139.80M, a decrease of -55.22%. That is a compound annual growth rate of -27.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 145.48M | 164.69% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |